about
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadActivation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.Signaling through C/EBP homologous protein and death receptor 5 and calpain activation differentially regulate THP-1 cell maturation-dependent apoptosis induced by Shiga toxin type 1Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a Survivin-targeted, amplifiable adenoviral vector.Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells.Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5Gene therapy in pancreatic cancer.Ubiquitination-dependent regulation of signaling receptors in cancer.Gingerol sensitizes TRAIL-induced apoptotic cell death of glioblastoma cellsMitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells.Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill.Induction of cellular prion protein (PrPc) under hypoxia inhibits apoptosis caused by TRAIL treatment.Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer.The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signalingInhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.Tagged and untagged TRAIL show different activity against tumor cells.The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.Immunomodulatory effects of interferons in malignancies.Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effectsTrail overexpression inversely correlates with histological differentiation in intestinal-type sinonasal adenocarcinoma.Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.MicroRNA-17-5p regulated apoptosis-related protein expression and radiosensitivity in oral squamous cell carcinoma caused by betel nut chewing.The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.Bufalin sensitizes human bladder carcinoma cells to TRAIL-mediated apoptosis.Distinct Osteomimetic Response of Androgen-Dependent and Independent Human Prostate Cancer Cells to Mechanical Action of Fluid Flow: Prometastatic Implications.Adipose‑derived mesenchymal stem cell‑facilitated TRAIL expression in melanoma treatment in vitro.Cellular Prion Protein (PrPc) and Hypoxia: True to Each Other in Good Times and in Bad, in Sickness, and in HealthMajor apoptotic mechanisms and genes involved in apoptosis.New phenazine analogues from Streptomyces sp. IFM 11694 with TRAIL resistance-overcoming activities.Periplasmic Expression of TNF Related Apoptosis Inducing Ligand (TRAIL) in E.coli.PCTAIRE1-knockdown sensitizes cancer cells to TNF family cytokines.Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis.Kurarinone Synergizes TRAIL-Induced Apoptosis in Gastric Cancer Cells.Effect of TRAIL in combination with DDP on the expression of MDR1 gene in gastric cancer cells.
P2860
Q28397132-388A0E01-7DC7-4790-9610-8880918BB271Q33564264-487D1570-569E-4536-98A4-AB787E958170Q33591623-AA3B1FAB-E5B8-45B4-92E1-219DCBED8DD6Q34042354-D1CEDDF8-8BA6-4683-95C9-489624A2D3F7Q34045050-202940C7-7531-4669-AFB3-AC77237D6B7EQ34134426-F7D5EB94-9EE1-4D3A-AA57-599BD22236B7Q34179539-6820D840-0280-4241-87A4-8A9A8BC7B550Q34292461-D24AC2C5-D161-4D86-8D1E-38C2A677A972Q34302954-5DFCED4B-457E-4190-AD49-E43DD767CA69Q34365210-5BA347C6-8652-4690-8E08-97433CB399E3Q34966112-E8DAF71F-A142-4196-A9C9-E2112F5CCCFDQ34980905-674DFB0C-566E-447D-84D2-77DC3005C4E1Q35501202-BE4CADBF-8981-486C-A54A-3F5263B08F86Q35681794-1663A69E-DCFD-4B87-BAA3-75004910AFB7Q35741681-D72A8F59-FBB7-4C7B-ACC8-41C29E06F08AQ35972500-6201E494-CA91-4EEE-A0A3-713E8B47FF11Q36180733-261D05A2-880F-40E5-B9FE-3A349012A477Q36340848-1AD889B7-4EC2-4CDB-A24F-79B0678B2B3CQ36424299-FC81DD26-942D-4AFD-9B99-7C8BDE62C3EDQ36725089-809056D2-8A28-4A74-99A2-11F1A3535D02Q36825411-E8E8EFC7-ACB5-4349-920B-EB271E1BB218Q37073589-12905051-839A-4839-A092-B53B22CD44C7Q37275272-B7BBA0CF-8628-4EB0-B6CB-5119AF620C7DQ37311413-A6A0278F-65FF-41C3-BD0B-DFB521CE1E84Q37588307-E1031037-66AA-411B-91B3-FAF92F2F23ACQ37688267-D70BE0D7-6CA8-4A92-A55B-C35E9E76468BQ37972139-086D692C-3CB0-4292-B071-05E6E858210CQ38175297-11694562-E399-4365-959E-D950084E2E55Q38664820-0F77CB8C-C825-4773-8A09-726E828F35EBQ38686012-6947A560-0891-432F-B134-A09B19EE8B23Q38733024-A872BBF1-B5D2-4ACC-B757-9DF7F7D759AFQ38771132-B9231847-5D4D-431B-A03E-AE3B8FD882C2Q38773206-73FD1EF4-189E-4CFB-ABE9-4C53EB1DE792Q38802454-2A39F3D3-62DD-4D08-BB46-B410F89A3967Q38811677-0C6A873D-C10E-429B-8CE2-AA6C4DE276EDQ38883656-C2855B48-15D0-441A-9EB7-FE99B0214177Q38897501-3DED5866-1FB2-4219-ACEC-53CCBEA33DA5Q38925560-2520D701-D1C6-4AC4-9C50-2EBA5433336CQ38927052-DEC49950-01BF-49AF-89F1-042CD7367DB4Q38951203-31161206-982F-4561-863F-22308F186272
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TRAIL as a target in anti-cancer therapy.
@en
TRAIL as a target in anti-cancer therapy.
@nl
type
label
TRAIL as a target in anti-cancer therapy.
@en
TRAIL as a target in anti-cancer therapy.
@nl
prefLabel
TRAIL as a target in anti-cancer therapy.
@en
TRAIL as a target in anti-cancer therapy.
@nl
P1433
P1476
TRAIL as a target in anti-cancer therapy.
@en
P2093
Gen Sheng Wu
P356
10.1016/J.CANLET.2009.02.029
P407
P577
2009-03-18T00:00:00Z